Linda S Harty
CIK 1388153 · last filed 2026-07-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PH price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
710 MEDTRONIC PARKWAY NE, LC-150
MINNEAPOLIS, MN 55432
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CHART INDUSTRIES INC (GTLS) Delisted | Director | 0 | $209.90 | $0 | $1.22M | 29 | 2026-07-16 |
| WAB | Director | 12,482 | $286.82 | $3.58M | -$654.7K | 16 | 2026-05-15 |
| PH | Director | 5,559 | $963.34 | $5.36M | -$3.50M | 34 | 2025-10-24 |
| Syneos Health, Inc. (SYNH) Delisted | Director | 8,006 | $42.98 | $344.1K | -$959.1K | 7 | 2022-05-27 |
| INCR | Director | 641 | $4.57 | $2.9K | $0 | 2 | 2017-05-24 |
Recent Filings · Page 7 of 9
90 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-21 | WAB | Grant (A) | +2,247 | $0 | EDGAR |
| 2019-02-28 | WAB | Sell (S) | −3,000 | -$227.0K | EDGAR |
| 2018-10-25 | PH | Grant (A) | +902 | $0 | EDGAR |
| 2018-05-25 | Syneos Health, Inc. (SYNH) Delisted | Grant (A) | +4,103 | $0 | EDGAR |
| 2018-05-16 | WAB | Grant (A) | +1,620 | $0 | EDGAR |
| 2017-11-21 | PH | Sell (S) | −3,491 | -$639.9K | EDGAR |
| 2017-10-26 | PH | Grant (A) | +885 | $0 | EDGAR |
| 2017-05-24 | INCR | Grant (A) | +2,693 | $0 | EDGAR |
| 2017-05-12 | WAB | Grant (A) | — | $0 | EDGAR |
| 2017-03-03 | INCR | Grant (A) | +514 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.